Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$435,819,734
+$36,883,005 QoQ
Shares Held
7,616,563
+7.9% QoQ
Ownership
3.93%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#8
of 564 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. BMRN ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in BMRN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $435,819,734 | 7,616,563 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $398,936,729 | 7,062,077 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $358,775,106 | 6,036,936 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $450,729,214 | 8,322,179 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $675,504,946 | 12,288,611 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $763,456,170 | 10,800,059 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $690,858,451 | 10,510,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $685,558,964 | 9,753,293 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $581,543,224 | 7,063,564 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $560,398,593 | 6,416,288 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $471,441,154 | 4,889,454 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $372,983,546 | 4,215,456 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $360,310,123 | 4,156,785 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $210,876,317 | 2,168,617 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $545,766,933 | 5,273,620 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $432,256,132 | 5,099,164 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $418,708,381 | 5,052,593 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $289,309,500 | 3,752,393 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $253,559,817 | 2,869,947 | Shares | Sole | 2022-05-16 | |
| 2020-03-31 | $122,831,312 | 1,453,625 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||